Main Article Content

Abstract

Background: Primary dysmenorrhea, marked by painful menstrual cramps without pelvic pathology, is prevalent among menstruating youth. It results from increased uterine contractions and ischemia due to elevated prostaglandin levels. Common treatments like NSAIDs and hormonal contraceptives may be ineffective or have adverse effects. Transcutaneous Electrical Nerve Stimulation (TENS), a non-pharmacological method delivering low-voltage electrical currents to the skin, offers a potential alternative. TENS is believed to relieve pain through gate control theory and the stimulation of endogenous opioid release. Despite growing interest, existing studies offer mixed results on its effectiveness and application parameters.


Methods: A systematic literature review was conducted using databases such as PubMed, Scopus, CINAHL, and Google Scholar, targeting studies from 2014 to 2024. Keywords included "TENS," "transcutaneous electrical nerve stimulation," "primary dysmenorrhea," and "non-pharmacological pain management." Studies selected included randomized controlled trials, quasi-experimental studies, and systematic reviews.


Results: Ten studies met inclusion criteria. Most found that TENS significantly reduced menstrual pain compared to placebo, no treatment, or conventional care. High-frequency TENS (80–100 Hz) applied to the lower abdomen or lumbosacral region showed the most benefit. Some studies also reported reduced analgesic use and improved daily functioning.


Conclusion: TENS appears to be a safe, well-tolerated, and potentially effective non-pharmacological treatment for primary dysmenorrhea. It offers pain relief and improves quality of life, making it a viable alternative to medication-based options.             

Keywords

Primary dysmenorrhea TENS transcutaneous electrical nerve stimulation menstrual pain non-pharmacological pain management high-frequency TENS women's health pain relief therapy

Article Details

How to Cite
PK. Mithila, & Jasmine Flora. (2025). An Evidence based review of effectiveness of TENS on women with primary dysmenorrhea. International Journal of Research in Pharmacology & Pharmacotherapeutics, 14(2), 368-375. Retrieved from https://ijrpp.com/ijrpp/article/view/671

References

  1. 1. Ferries-Rowe E, Corey E, Archer JS. Primary Dysmenorrhea: Diagnosis and Therapy. Obstet Gynecol. 2020 Nov;136(5):1047-1058. doi: 10.1097/AOG.0000000000004096. PMID: 33030880.
  2. 2. Guimarães I, Póvoa AM. Primary Dysmenorrhea: Assessment and Treatment. Rev Bras Ginecol Obstet. 2020 Aug;42(8):501-507. doi: 10.1055/s-0040-1712131. Epub 2020 Jun 19. PMID: 32559803; PMCID: PMC10309238.
  3. 3. Guy M, Foucher C, Juhel C, Rigaudier F, Mayeux G, Levesque A. Transcutaneous electrical neurostimulation relieves primary dysmenorrhea: A randomized, double-blind clinical study versus placebo. Prog Urol. 2022 Jul;32(7):487-497. doi: 10.1016/j.purol.2022.01.005. Epub 2022 Mar 3. PMID: 35249825.
  4. 4. Arik MI, Kiloatar H, Aslan B, Icelli M. The effect of TENS for pain relief in women with primary dysmenorrhea: A systematic review and meta-analysis. Explore (NY). 2022 Jan-Feb;18(1):108-113. doi: 10.1016/j.explore.2020.08.005. Epub 2020 Aug 29. PMID: 32917532.
  5. 5. Igwea SE, Tabansi-Ochuogu CS, Abaraogu UO. TENS and heat therapy for pain relief and quality of life improvement in individuals with primary dysmenorrhea: A systematic review. Complement Ther Clin Pract. 2016 Aug;24:86-91. doi: 10.1016/j.ctcp.2016.05.001. Epub 2016 May 7. PMID: 27502806.
  6. 6. Elboim-Gabyzon M, Kalichman L. Transcutaneous Electrical Nerve Stimulation (TENS) for Primary Dysmenorrhea: An Overview. Int J Womens Health. 2020 Jan 8;12:1-10. doi: 10.2147/IJWH.S220523. PMID: 32021488; PMCID: PMC6955615.
  7. 7. Perez Machado AF, Perracini MR, Cruz Saraiva de Morais AD, da Silva BO, Driusso P, Liebano RE. Microwave diathermy and transcutaneous electrical nerve stimulation effects in primary dysmenorrhea: clinical trial protocol. Pain Manag. 2017 Sep;7(5):359-366. doi: 10.2217/pmt-2017-0021. Epub 2017 Sep 22. PMID: 28936905.
  8. 8. Dawood MY, Ramos J. Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen. Obstet Gynecol. 1990 Apr;75(4):656-60. PMID: 2179780.
  9. 9. Han S, Park KS, Lee H, Kim E, Zhu X, Lee JM, Suh HS. Transcutaneous electrical nerve stimulation (TENS) for pain control in women with primary dysmenorrhoea. Cochrane Database Syst Rev. 2024 Jul 22;7(7):CD013331. doi: 10.1002/14651858.CD013331.pub2. PMID: 39037764; PMCID: PMC11262556.
  10. 10. Machado AFP, Perracini MR, Rampazo ÉP, Driusso P, Liebano RE. Effects of thermotherapy and transcutaneous electrical nerve stimulation on patients with primary dysmenorrhea: A randomized, placebo-controlled, double-blind clinical trial. Complement Ther Med. 2019 Dec;47:102188. doi: 10.1016/j.ctim.2019.08.022. Epub 2019 Aug 28. PMID: 31779988.
  11. 11. Lee B, Hong SH, Kim K, Kang WC, No JH, Lee JR, Jee BC, Yang EJ, Cha EJ, Kim YB. Efficacy of the device combining high-frequency transcutaneous electrical nerve stimulation and thermotherapy for relieving primary dysmenorrhea: a randomized, single-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:58-63. doi: 10.1016/j.ejogrb.2015.08.020. Epub 2015 Aug 22. PMID: 26340453.
  12. 12. Camilo FM, Bossini PS, Driusso P, Ávila MA, Parizotto NA, de Sousa UR, Rodrigo Ramos R. The Effects of Electrode Placement on Analgesia Using Transcutaneous Electrical Nerve Stimulation for Primary Dysmenorrhea: A Single-Blind Randomized Controlled Clinical Trial. Cureus. 2023 May 22;15(5):e39326. doi: 10.7759/cureus.39326. PMID: 37378135; PMCID: PMC10292036.
  13. 13. Manisha U, Anuradha L. Effect of high frequency transcutaneous electrical nerve stimulation at root level menstrual pain in primary dysmenorrhea. J Bodyw Mov Ther. 2021 Apr;26:108-112. doi: 10.1016/j.jbmt.2020.12.025. Epub 2020 Dec 28. PMID: 33992229.
  14. 14. Lauretti GR, Oliveira R, Parada F, Mattos AL. The New Portable Transcutaneous Electrical Nerve Stimulation Device Was Efficacious in the Control of Primary Dysmenorrhea Cramp Pain. Neuromodulation. 2015 Aug;18(6):522-6; discussion 522-7. doi: 10.1111/ner.12269. Epub 2015 Feb 5. PMID: 25655828.
  15. 15. Bai HY, Bai HY, Yang ZQ. Effect of transcutaneous electrical nerve stimulation therapy for the treatment of primary dysmenorrheal. Medicine (Baltimore). 2017 Sep;96(36):e7959. doi: 10.1097/MD.0000000000007959. PMID: 28885348; PMCID: PMC6392990.
  16. 16. Ferries-Rowe E, Corey E, Archer JS. Primary Dysmenorrhea: Diagnosis and Therapy. Obstet Gynecol. 2020 Nov;136(5):1047-1058. doi: 10.1097/AOG.0000000000004096. PMID: 33030880.
  17. 17. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006 Aug;108(2):428-41. doi: 10.1097/01.AOG.0000230214.26638.0c. PMID: 16880317.
  18. 18. Kannan P, Claydon LS. Some physiotherapy treatments may relieve menstrual pain in women with primary dysmenorrhea: a systematic review. J Physiother. 2014 Mar;60(1):13-21. doi: 10.1016/j.jphys.2013.12.003. Epub 2014 Apr 24. PMID: 24856936.
  19. 19. Karout S, Soubra L, Rahme D, Karout L, Khojah HMJ, Itani R. Prevalence, risk factors, and management practices of primary dysmenorrhea among young females. BMC Womens Health. 2021 Nov 8;21(1):392. doi: 10.1186/s12905-021-01532-w. PMID: 34749716; PMCID: PMC8576974.